Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Biomerica stock

Learn how to easily invest in Biomerica stock.

Biomerica Inc is a medical devices business based in the US. Biomerica shares (BMRA) are listed on the NASDAQ and all prices are listed in US Dollars. Biomerica employs 64 staff and has a trailing 12-month revenue of around $18.9 million.

How to buy shares in Biomerica

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BMRA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Biomerica stock price (NASDAQ: BMRA)

Use our graph to track the performance of BMRA stocks over time.

Biomerica shares at a glance

Information last updated 2022-10-03.
Latest market close$4.14
52-week range$2.56 - $7.38
50-day moving average $3.33
200-day moving average $3.68
Wall St. target price$13.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.28

Buy Biomerica shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Biomerica stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Biomerica price performance over time

Historical closes compared with the close of $4.14 from 2022-10-03

1 week (2022-09-28) 5.61%
1 month (2022-09-01) N/A
3 months (2022-07-05) 42.76%
6 months (2022-04-05) -7.17%
1 year (2021-10-05) -30.19%
2 years (2020-10-05) -41.94%
3 years (2019-10-04) 29.38%
5 years (2017-10-04) 45.26%

Biomerica financials

Revenue TTM $18.9 million
Gross profit TTM $3 million
Return on assets TTM -24.44%
Return on equity TTM -51.63%
Profit margin -24.01%
Book value $0.65
Market capitalisation $52.7 million

TTM: trailing 12 months

Biomerica share dividends

We're not expecting Biomerica to pay a dividend over the next 12 months.

Have Biomerica's shares ever split?

Biomerica's shares were split on a 1:2 basis on 13 November 1994. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Biomerica shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for Biomerica shares which in turn could have impacted Biomerica's share price.

Biomerica share price volatility

Over the last 12 months, Biomerica's shares have ranged in value from as little as $2.56 up to $7.38. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Biomerica's is -0.4403. This would suggest that Biomerica's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Biomerica has bucked the trend.

Biomerica overview

Biomerica, Inc. , a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; Helicobacter pylori test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19.

Frequently asked questions

What percentage of Biomerica is owned by insiders or institutions?
Currently 8.948% of Biomerica shares are held by insiders and 18.129% by institutions.
How many people work for Biomerica?
Latest data suggests 64 work at Biomerica.
When does the fiscal year end for Biomerica?
Biomerica's fiscal year ends in May.
Where is Biomerica based?
Biomerica's address is: 17571 Von Karman Avenue, Irvine, CA, United States, 92614
What is Biomerica's ISIN number?
Biomerica's international securities identification number is: US09061H3075
What is Biomerica's CUSIP number?
Biomerica's Committee on Uniform Securities Identification Procedures number is: 09061H307

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site